Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Infect Prev Pract ; 3(1): 100122, 2021 Mar.
Article in English | MEDLINE | ID: mdl-34368739

ABSTRACT

BACKGROUND: Hand washing is an important targeted hygiene intervention for limiting the spread of infectious agents, including the Ebola virus, which continues to re-emerge. We have assessed the virucidal efficacy of a commercially available liquid hand wash product (LHW) for inactivating Ebola virus. METHODS: The ASTM E1052-11 Standard was used to evaluate the efficacy of an LHW containing the microbicidal active salicylic acid for inactivating Ebola virus - Makona variant suspended in an organic load. Three concentrations (12.5%, 25%, 50%) of three lots of LHW prepared in 440 ppm hard water were evaluated at room temperature for 20, 30, and 60 s contact time. RESULTS: A 25% solution of the LHW caused 4.5 log10 and 4.8 log10 reduction in Ebola virus titer within 20 and 30 s, respectively. The efficacy of a 12.5% LHW solution was lower (1.9 and 2.0 log10 reduction in titer within 20 and 30 s, respectively). The efficacy of the 50% LHW solution could not be measured, due to inability to sufficiently neutralize the LHW at the end of exposure. CONCLUSION: These results suggest the potential utility of an appropriately formulated liquid hand wash agent during Ebola virus disease outbreaks for use within healthcare, community, and home settings. Such an LHW should also be effective against other enveloped viruses, such as the pandemic coronavirus SARS-CoV-2.

2.
BMC Res Notes ; 13(1): 291, 2020 Jun 15.
Article in English | MEDLINE | ID: mdl-32539799

ABSTRACT

OBJECTIVES: Mouse models have delivered variable recapitulation of Kyasanur Forest disease (KFD) pathology and consistently demonstrated neurological involvement which may be a limited feature of human disease. With the purpose of more accurately modelling human disease progression we infected several small-mammalian models: guinea pigs, hamsters and ferrets with a titered infectious dose of Kyasanur Forest disease virus (KFDV). Clinical indicators of disease severity were observed for seventeen days, on day eighteen a visual post-mortem analysis of visceral organs was conducted. Viral load in selected tissues was measured to infer disease signs and the establishment of viral replication. DATA DESCRIPTION: Daily monitoring did not reveal any observable signs of illness; weight loss was minimal across species and gross pathology did not indicate severe viral infection. Tissue specific tropism and establishment of viral infection was monitored by quantitative real-time polymerase chain reaction (qRT-PCR). No viral replication was detected in ferrets (n = 0/3), but was present in the spleen of guinea pigs (n = 3/3) and the brain of hamsters (n = 3/3). Low levels of viral RNA were detected in multiple hamster tissues (kidney, liver, lung and spleen) suggesting the possibility of viral tropism and possible adaptation to the host. No serological tests were performed.


Subject(s)
Flavivirus/physiology , Flavivirus/pathogenicity , Kyasanur Forest Disease/virology , Viral Tropism , Virus Replication , Animals , Cricetinae , Datasets as Topic , Disease Models, Animal , Ferrets , Guinea Pigs , Pilot Projects , Severity of Illness Index
3.
Can Commun Dis Rep ; 43(1): 25-28, 2017 Jan 05.
Article in English | MEDLINE | ID: mdl-29770044

ABSTRACT

The advice contained in this document should be read in conjunction with relevant federal, provincial, territorial and local legislation, regulations, and policies. Recommended measures should not be regarded as rigid standards, but principles and recommendations to inform the development of guidance. This advice is based on currently available scientific evidence and adopts a precautionary approach where the evidence is lacking or inconclusive. It was approved for publication on December 5, 2016. It is subject to review and change as new information becomes available. The main changes to this version include additions to: Case load reported to date, Sarcoidosis-like disease as an Indicator, Whole Genome Sequencing effort, links to Provincial and Territorial Lab Services and Health Canada reporting.

4.
BJOG ; 122(3): 402-10, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25175335

ABSTRACT

OBJECTIVE: To investigate the performance of a multivariable model combining a priori clinical characteristics and biomarkers to detect, early in pregnancy, women at higher risk of developing pre-eclampsia (PE). DESIGN: Nested case-control study. SETTING: University medical centre, Quebec, Canada (CHU de Québec). POPULATION: A total of 7929 pregnant women recruited between 10 and 18 weeks of gestation. In all, 350 developed hypertensive disorders of pregnancy (HDP)-of which 139 had PE, comprising 68 with severe PE and 47 with preterm PE-and were matched with two women with a normal pregnancy. METHODS: We selected a priori clinical characteristics and promising markers to create multivariable logistic regression models: body mass index (BMI), mean arterial pressure (MAP), placental growth factor, soluble Fms-like tyrosine kinase-1, pregnancy-associated plasma protein A and inhibin A. MAIN OUTCOME MEASURES: PE, severe PE, preterm PE, HDP. RESULTS: At false-positive rates of 5 and 10%, the estimated detection rates were between 15% (5-29%) and 32% (25-39%), and between 39% (19-59%) and 50% (34-66%), respectively. Considering the low prevalence of PE in this population, the positive predictive values were 7% (5-9%) to 10% (7-13%) for PE and 2% (1-4%) to 4% (3-6%) in the preterm and severe PE subgroups. The multivariable model yielded areas under the receiver operating characteristics curves (AUC) between 0.72 (0.61-0.81) and 0.78 (0.68-0.88). When only BMI and MAP were included in the model, the AUC were similar to those of the a priori model. CONCLUSIONS: In a population with a low prevalence of preterm PE, a multivariable risk algorithm using an a priori combination of clinical characteristics and biochemical markers did not reach a performance justifying clinical implementation as screening test early in pregnancy.


Subject(s)
Hypertension, Pregnancy-Induced/blood , Inhibins/blood , Pre-Eclampsia/blood , Pregnancy Complications, Cardiovascular/blood , Pregnancy Proteins/blood , Pregnancy-Associated Plasma Protein-A/metabolism , Vascular Endothelial Growth Factor Receptor-1/blood , Arterial Pressure , Biomarkers/blood , Blood Pressure , Canada , Female , Humans , Hypertension, Pregnancy-Induced/prevention & control , Mass Screening , Placenta Growth Factor , Pre-Eclampsia/prevention & control , Predictive Value of Tests , Pregnancy , Pregnancy Complications, Cardiovascular/prevention & control , Pregnancy Trimester, First/blood , Pulsatile Flow , Risk Assessment
5.
Pregnancy Hypertens ; 2(3): 227, 2012 Jul.
Article in English | MEDLINE | ID: mdl-26105305

ABSTRACT

INTRODUCTION: The advent of early preventive measures, such as low-dose aspirin targeting women at high risk of preeclampsia (PE), emphasizes the need for better detection. Despite the emergence of promising biochemical markers linked to the pathophysiological processes, systematic reviews have shown that, until now, no single tests fulfill the criteria set by WHO for biomarkers to screen for a disease. However, recent literature reveals that by combining various clinical, biophysical and biochemical markers into multivariate algorithms, one can envisage to estimate the risk of PE with a performance that would reach clinical utility and cost-effectiveness, but this remains to be demonstrated in various environments and health care settings. OBJECTIVES: To investigate, in a prospective study, the clinical utility of candidate biomarkers and clinical data to detect, early in pregnancy, women at risk to develop PE and to propose a multivariate prediction algorithm combining clinical parameters to biochemical markers. METHODS: 7929 pregnant women prospectively recruited at the first prenatal visit, provided blood samples, clinical and sociodemographic information. 214 pregnant women developed hypertensive disorders of pregnancy (HDP) of which 88 had PE (1.2%), including 44 with severe PE (0.6%). A nested case-control study was performed including for each case of HDP two normal pregnancies matched for maternal age, gestational age at recruitment, ethnicity, parity, and smoking status. Based on the literature we selected the most promising markers in a multivariate logistic regression model: mean arterial pressure (MAP), BMI, placental growth factor (PlGF), soluble Flt-1, inhibin A and PAPP-A. Biomarker results measured between 10-18 weeks gestation were expressed as multiples of the median. Medians were determined for each gestational week. RESULTS: When combined with MAP at the time of blood sampling and BMI at the beginning of pregnancy, the four biochemical markers discriminate normal pregnancies from those with HDP. At a 5% false positive rate, 37% of the affected pregnancies would have been detected. However, considering the prevalence of HDP in our population, the positive predictive value would have been only 15%. If all the predicted positive women would have been proposed a preventive intervention, only one out 6.7 women could have potentially benefited. In the case of severe PE, performance was not improved, sensitivity was the same, but the positive predictive value decreased to 3% (lower prevalence of severe PE). CONCLUSION: In our low-risk Caucasian population, neither individual candidate markers nor multivariate risk algorithm using an a priori combination of selected markers reached a performance justifying implementation. This also emphasizes the necessity to take into consideration characteristics of the population and environment influencing prevalence before promoting wide implementation of such screening strategies. In a perspective of personalized medicine, it appears more than ever mandatory to tailor recommendations for HDP screening according not only to individual but also to population characteristics.

6.
J Appl Microbiol ; 110(2): 455-62, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21114595

ABSTRACT

AIMS: This study was undertaken to determine the effectiveness of biological indicators currently being employed during formaldehyde decontamination. Data suggest that detectable amounts of formaldehyde are absorbed into the paper strips contained in currently used biological indicators. Absorbed formaldehyde has the potential to inhibit the growth of indicator spores, thus leading to false negative results. Indicators composed of either stainless steel carriers or paper strips were investigated to determine whether stainless steel carriers can be used as an alternative to paper strip indicators. METHODS AND RESULTS: Biological indicators were exposed to formaldehyde gas and were tested for the presence of formaldehyde and any possible inhibition of spore growth. Absorbed formaldehyde was detected in the paper strip carriers while no formaldehyde was detected from any of the stainless steel carriers. Exposed paper strips were found to inhibit growth of up to 1 × 10(6) spores while the stainless steel carriers did not inhibit the growth of spores. CONCLUSIONS: During decontamination, biological indicators composed of paper spore strips absorb formaldehyde and inhibit growth of any surviving spores. Stainless steel carriers do not absorb formaldehyde and are an ideal alternative substrate for biological indicators. SIGNIFICANCE AND IMPACT OF THE STUDY: The popular paper strip biological indicator can lead to false negative results during decontamination and is unsuitable for validating formaldehyde decontamination.


Subject(s)
Decontamination/methods , Disinfectants/pharmacology , Formaldehyde/pharmacology , Stainless Steel , Bacillus/drug effects , Bacillus/growth & development , Disinfectants/analysis , Formaldehyde/analysis , Gases , Indicators and Reagents , Methenamine/analysis , Paper , Spores, Bacterial/drug effects , Spores, Bacterial/growth & development
7.
Arch Virol Suppl ; (19): 157-77, 2005.
Article in English | MEDLINE | ID: mdl-16355872

ABSTRACT

The family Filoviridae is comprised of two genera: Marburgvirus and Ebolavirus. To date minigenome systems have been developed for two Ebola viruses (Reston ebolavirus and Zaire ebolavirus [ZEBOV]) as well as for Lake Victoria marburgvirus, the sole member of the Marburgvirus genus. The use of these minigenome systems has helped characterize functions for many viral proteins in both genera and have provided valuable insight towards the development of an infectious clone system in the case of ZEBOV. The recent development of two such infectious clone systems for ZEBOV now allow effective strategies for experimental mutagenesis to study the biology and pathogenesis of one of the most lethal human pathogens.


Subject(s)
Filoviridae Infections/physiopathology , Filoviridae/pathogenicity , Hemorrhagic Fever, Ebola/physiopathology , Animals , Filoviridae/genetics , Filoviridae/immunology , Filoviridae Infections/immunology , Hemorrhagic Fever, Ebola/transmission , Humans
8.
Can J Anaesth ; 43(6): 585-8, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8773865

ABSTRACT

PURPOSE: The objective of the present prospective study was to evaluate the influence of neuromuscular monitoring on the level of neuromuscular blockade from induction of anaesthesia until extubation of the trachea. METHODS: Forty-two patients aged between 18 and 73 yr undergoing a range of surgical procedures under general anaesthesia were randomly distributed into two groups of 21 patients each. In both groups a Datex NMT Monitor was used and electromyographic responses of the ulnar muscles to supramaximal stimulation of the ulnar nerve were recorded. In Group 1, the anaesthetist could see the movements of the stimulated hand, but not the monitor. In Group 2, the anaesthetist could see neither the stimulated hand nor the monitor. The same anaesthetist administered the neuromuscular relaxants which were succinylcholine 1.5 mg.kg-1 for tracheal intubation and vecuronium 0.1 mg.kg-1 for neuromuscular relaxation during surgery, followed by 1 to 2 mg maintenance injections. Possible residual curarization was evaluated in the recovery room by head life tests and pulse oximetry. RESULTS: Patients in Group 1 had deeper neuromuscular block throughout surgery, despite the use of a comparable dose of vecuronium (10.1 mg for G1 vs 11.2 mg for G2). The EMG values of T1 and train-of-four values were not different at tracheal intubation or at extubation. No patients presented signs of residual curarization in the recovery room. CONCLUSION: The study demonstrates that with the same amount of vecuronium the neuromuscular relaxation was deeper with the use of a simple neuromuscular monitoring (visual evaluation of the thumb movements). Despite the deeper neuromuscular block in the monitored group, there was no residual curarization in the recovery room.


Subject(s)
Monitoring, Intraoperative , Neuromuscular Depolarizing Agents/pharmacology , Neuromuscular Junction/drug effects , Neuromuscular Nondepolarizing Agents/pharmacology , Succinylcholine/pharmacology , Vecuronium Bromide/pharmacology , Adolescent , Adult , Aged , Anesthesia Recovery Period , Anesthesia, General , Electromyography/drug effects , Female , Humans , Intubation, Intratracheal , Male , Middle Aged , Muscle Contraction/drug effects , Muscle, Skeletal/drug effects , Muscle, Skeletal/innervation , Neck Muscles/drug effects , Neck Muscles/physiology , Neuromuscular Depolarizing Agents/administration & dosage , Neuromuscular Junction/physiology , Neuromuscular Nondepolarizing Agents/administration & dosage , Oximetry , Prospective Studies , Succinylcholine/administration & dosage , Ulnar Nerve/drug effects , Vecuronium Bromide/administration & dosage
9.
Opt Lett ; 20(12): 1438-40, 1995 Jun 15.
Article in English | MEDLINE | ID: mdl-19862041

ABSTRACT

A simple method is described that permits the spectral response (spectral width, shape, and center resonant wavelength) of an optical waveguide Bragg grating to be controlled accurately in a prescribed manner. The control methodology consists of bonding the Bragg grating along the length of a mechanical support structure, which is then loaded with an appropriate force distribution. The function of the support structure is to transfer the strain induced by loading to the grating, thus modifying the grating's spectral response in accordance with the variation in effective optical pitch induced by the strain transfer. We design and demonstrate a support structure that provides independent control over the spectral width and center wavelength of a Bragg grating.

10.
Opt Lett ; 19(17): 1314-6, 1994 Sep 01.
Article in English | MEDLINE | ID: mdl-19855505

ABSTRACT

A linearly chirped in-fiber Bragg grating is reported that can compensate at 1549 nm for the dispersion [ approximately -19 ps/(nmkm)] of standard telecommunications optical fiber optimized for 1300-nm operation.

11.
Immunol Lett ; 34(3): 213-9, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1487308

ABSTRACT

Enzyme immunoassays (EIA) capable of determining total IgG1, IgG2, IgG3 and IgG4 subclass concentrations in human serum preparations have been developed. Subclass-specific monoclonal antibodies (mAbs) are bound to polyacrylamide bead-conjugated anti-mouse immunoglobulin antibodies. Bound immunoglobulins are detected with a peroxidase-conjugated anti-IgG antibody or a biotin-conjugated anti-IgG antibody followed by peroxidase streptavidin. The standard curves were found to be linear in the regions 16.0-2.0 micrograms/ml for IgG1, 4.0-0.5 micrograms/ml for IgG2, 0.4-0.06 micrograms/ml for IgG3 and 0.25-0.05 micrograms/ml for IgG4. Coefficient of variation (CV) values range from 0.32-7.32% for IgG1, 0.66-4.85% for IgG2, 1.62-6.85% for IgG3 and 0.05-6.47% for IgG4 standard curves. The inter-assay variability for the control human serum samples was 9.6% for IgG1, 6.7% for IgG2, 9.5% for IgG3 and 6.8% for IgG4.


Subject(s)
Immunoenzyme Techniques , Immunoglobulin G/analysis , Adolescent , Antibodies, Monoclonal , Child , Humans , Immunodiffusion , Immunoglobulin Isotypes/analysis , Lung Diseases/immunology , Paranasal Sinus Diseases/immunology , Reference Standards , Sensitivity and Specificity
12.
Opt Lett ; 16(17): 1298-300, 1991 Sep 01.
Article in English | MEDLINE | ID: mdl-19776950

ABSTRACT

We report our first results on the frequency control of an AlGaAs laser diode by resonant phase-conjugate reflection from an atomic rubidium vapor. When the electrical feedback technique is used, the Allan variance reaches a flicker floor such that sigma(y)(2)(tau) = 1.6 x 10(-19) tau(0) for tau > 1s. We also demonstrate that laser frequency locking can be achieved by using the phase-conjugate reflection directly as a resonant optical feedback. This approach leads to a self-controlled optical frequency standard at 780 nm.

SELECTION OF CITATIONS
SEARCH DETAIL
...